With the exception of CD97, which is uniformly highly expressed in all samples tested, GPCR expression was distributed unequally within each patient sample highlighting the possibility of defining AML subpopulations with these protein markers (Supplementary Figure 5). This evidence concerns the gene ADGRE2 and acute myeloid leukemia.